Elutia Inc. (ELUT) stock
ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/309% below fair value
$0.81−0.02 (-2.41%)
Close on Nov 19, 2026Market cap $35.87MP/E –Yield –
Elutia shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Elutia's shares outstanding was 44M at Jun 30, 2026. For fiscal 2025 it was 46M, up 58.0% from the year before. The highest annual figure on record is 46M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 46M | +58.0% |
| FY2024 | Dec 31, 2024 | 29M | +60.1% |
| FY2023 | Dec 31, 2023 | 18M | +31.3% |
| FY2022 | Dec 31, 2022 | 14M | +32.4% |
| FY2021 | Dec 31, 2021 | 10M | +266.2% |
| FY2020 | Dec 31, 2020 | 3M | +341.6% |
| FY2019 | Dec 31, 2019 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 44M | -4.5% |
| Q1 FY2026 | Mar 31, 2026 | 43M | +0.2% |
| Q4 FY2025 | Dec 31, 2025 | 47M | +35.6% |
| Q3 FY2025 | Sep 30, 2025 | 47M | +32.2% |
| Q2 FY2025 | Jun 30, 2025 | 46M | +86.0% |
| Q1 FY2025 | Mar 31, 2025 | 43M | +79.5% |
| Q4 FY2024 | Dec 31, 2024 | 35M | +50.1% |
| Q3 FY2024 | Sep 30, 2024 | 36M | +108.7% |
| Q2 FY2024 | Jun 30, 2024 | 25M | +53.5% |
| Q1 FY2024 | Mar 31, 2024 | 24M | +48.1% |
| Q4 FY2023 | Dec 31, 2023 | 23M | +70.7% |
| Q3 FY2023 | Sep 30, 2023 | 17M | +25.4% |
| Q2 FY2023 | Jun 30, 2023 | 16M | +46.3% |
| Q1 FY2023 | Mar 31, 2023 | 16M | +57.8% |
| Q2 FY2022 | Jun 30, 2022 | 14M | +33.2% |
| Q1 FY2022 | Mar 31, 2022 | 14M | +32.7% |
| Q4 FY2021 | Dec 31, 2021 | 11M | +1610.1% |
| Q3 FY2021 | Sep 30, 2021 | 10M | +1478.9% |
| Q2 FY2021 | Jun 30, 2021 | 10M | +1477.8% |
| Q1 FY2021 | Mar 31, 2021 | 10M | +1476.8% |
| Q3 FY2020 | Sep 30, 2020 | 1M | +0.5% |
| Q2 FY2020 | Jun 30, 2020 | 1M | – |
| Q1 FY2020 | Mar 31, 2020 | 1M | – |
| Q4 FY2019 | Dec 31, 2019 | 1M | – |
| Q3 FY2019 | Sep 30, 2019 | 1M | – |
See a number that looks wrong?